Company Filing History:
Years Active: 1997
Title: Arthur H Bertelsen: Innovator in Tumor Suppressor Research
Introduction
Arthur H Bertelsen is a notable inventor based in Ridgewood, NJ (US), recognized for his contributions to the field of biotechnology. He holds two patents that focus on innovative vector systems and their applications in cancer research. His work has significant implications for therapeutic approaches in oncology.
Latest Patents
Bertelsen's latest patents include advancements in vectors and vector systems that incorporate genes encoding tumor suppressor proteins. One of the key embodiments involves a vector that includes a gene encoding the p53 tumor suppressor protein, controlled by an inducible promoter. Additionally, he has developed vector systems that consist of multiple vectors, one containing a gene encoding a tumor suppressor protein and another containing an antisense sequence that complements the tumor suppressor gene. These innovations enable the proliferation of cells transformed by these vectors, allowing for the harvesting of infectious viral particles for patient administration. Another significant patent involves oligonucleotides that bind to and modulate the activity of interferon-gamma, providing potential therapeutic and diagnostic methods.
Career Highlights
Throughout his career, Bertelsen has worked with prominent companies in the biotechnology sector, including Genzyme Corporation and Pharmagenics, Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions for complex medical challenges.
Collaborations
Bertelsen has collaborated with notable professionals in his field, including Gary A Beaudry and Michael I Sherman. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
Arthur H Bertelsen's work in vector systems and tumor suppressor research exemplifies the innovative spirit of modern biotechnology. His patents reflect a commitment to advancing therapeutic options for cancer treatment, showcasing the importance of innovation in the medical field.